Dgs Capital Management, LLC Eagle Pharmaceuticals, Inc. Transaction History
Dgs Capital Management, LLC
- $355 Million
- Q3 2024
A detailed history of Dgs Capital Management, LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Dgs Capital Management, LLC holds 71,728 shares of EGRX stock, worth $37,298. This represents 0.07% of its overall portfolio holdings.
Number of Shares
71,728
Previous 49,489
44.94%
Holding current value
$37,298
Previous $277,000
3.97%
% of portfolio
0.07%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding EGRX
# of Institutions
70Shares Held
8.6MCall Options Held
1MPut Options Held
100-
Nantahala Capital Management, LLC New Canaan, CT2.36MShares$1.23 Million0.52% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.21MShares$629,9841.82% of portfolio
-
Citigroup Inc1MShares$520,2020.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA580KShares$301,3430.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT375KShares$194,9950.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $6.77M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...